Pluristem Therapeutics ( PSTI) is a bio-therapeutics Company dedicated to the commercialization of non-personalized cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders. This stock is trading up 12.5% to $4.72 in recent trading. Today's Range: $4.51-$4.90 52-Week Range: $1.98-$5.00 Volume: 3 million Three-Month Average Volume: 840,916 >>5 Technical Trades Under $5 Shares of PSTI are ripping higher today after the company said a third critically ill patient was successfully treated with its Placental eXpanded cells under compassionate use. The company said the outcome of its recent success with PLX cells suggest it may have significant potential to treat a range of indications of bone marrow diseases. From a technical perspective, PSTI is gapping up big here with monster volume. This move is quickly pushing PSTI within range of triggering a major breakout trade. That trade will hit once PSTI takes out some near-term overhead resistance and its 52-week high at $5 with high volume. Traders should now look for long-biased trades in PSTI once it sustains a move or close above $5 with volume that's near or above 840,916 shares. If that breakout triggers soon, then PSTI will have a great chance of hitting $6 to $7 in the near future. Traders should use $4.50 as near-term support if PSTI can hold this gap and potentially breakout soon. Any high-volume move below $4.50 could send PSTI back towards $4.25 to $4, before it possibly sets up again to attempt the breakout.